Intrommune Therapeutics Presents Supporting Data : compareme

OMIT (Oral Mucosal Immunotherapy) is a new approach to the management of food allergy demonstrating a robust immunologic response in treated subjects...

Related Keywords

Washington , District Of Columbia , United States , American , Jen Zoller , Stuart Loesch , Williame Berger , Drug Administration , American Academy Of Allergy , Green Room Communications , Intrommune Therapeutics Inc , American Academy , Annual Scientific Meeting , Oral Food Challenge , United States Food , Intrommune Therapeutics , Peanut Allergy , Food Allergy , Mit , Clinical Trial , Ealthcareinnovation , Biotechnology ,